Inhibitory effects of processed Aconiti tuber on morphine-induced conditioned place preference in rats

Journal of Ethnopharmacology

Volumn 136, Issue 1, 2011, Pages 254-259

  Wu, Guiyun ^a   Huang, Wenqi ^a   Zhang, Hui ^a   Li, Qiaobo ^a   Zhou, Jun ^a   Shu, Haihua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Conditioned place preference; Dynorphin; Kappa opioid receptor; Morphine; Processed Aconiti tuber

Indexed keywords

CHINESE DRUG; DYNORPHIN; MORPHINE; NORBINALTORPHIMINE; PROCESSED ACONITI TUBER; SODIUM CHLORIDE; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; HYPOTHESIS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PROTEIN SECRETION; RADIOIMMUNOASSAY; RAT;

ACONITUM; ANIMALS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; DRUGS, CHINESE HERBAL; DYNORPHINS; MALE; MORPHINE DEPENDENCE; NALTREXONE; NARCOTIC ANTAGONISTS; NUCLEUS ACCUMBENS; PHYTOTHERAPY; PLANT TUBERS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA;

RATTUS;

EID: 79958105029     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2011.04.041     Document Type: Article

References (40)

1. Arita, H., Hayashida, M., Shu, H., Xu, H., Sekiyama, H., Hanaoka, K., 2007. Application of herb medicine in pain clinic-focusing on the basic research of Aconiti tuber. Masui 56 (Suppl. S), 199-211 (article in Japanese).
2. Bardo, M.T., Bevins, R.A., 2000. Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl) 153, 31-43.
3. Bart, G., Borg, L., Schluger, J.H., Green, M., Ho, A., Kreek, M.J., 2003. Suppressed prolactin response to dynorphin A1-13 in methadone-maintained versus control subjects. Journal of Pharmacology and Experimental Therapeutics 306, 581-587. (Pubitemid 36886157)
4. Bruchas, M.R., Chavkin, C., 2010. Kinase cascades and ligand-directed signaling at the kappa opioid receptor. Psychopharmacology (Berl) 210, 137-147.
5. Dortch-Carnes, J., Potter, D.E., 2005. Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties. CNS Drug Reviews 11, 195-212. (Pubitemid 41278982)
6. Eguchi, M., 2004. Recent advances in selective opioid receptor agonists and antagonists. Medicinal Research Reviews 24, 182-212. (Pubitemid 38230679)
7. Everitt, B.J., Wolf, M.E., 2002. Psychomotor stimulant addiction: a neural systems perspective. Journal of Neuroscience 22, 3312-3320. (Pubitemid 37465734)
8. Funada, M., Suzuki, T., Narita, M.,Misawa, M., Nagase, H., 1993. Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Neuropharmacology 32, 1315-1323. (Pubitemid 24023014)
9. Glick, S.D., Maisonneuve, I.M., Raucci, J., Archer, S., 1995. Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Research 681, 147-152.
10. Harris, G.C., Hummel, M.,Wimmer, M.,Mague, S.D., Aston-Jones, G., 2007. Elevations of FosB in the nucleus accumbens during forced cocaine abstinence correlate with divergent changes in reward function. Neuroscience 147, 583-591. (Pubitemid 46990649)
11. Hurd, Y.L., 1996. Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain. Neuroscience 72, 767-783. (Pubitemid 26124696)
12. Koob, G.F., 1992. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends in Pharmacological Sciences 13, 177-184.
13. Kreek, M.J., Schluger, J., Borg, L., Gunduz, M., Ho, A., 1999. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions. Journal of Pharmacology and Experimental Therapeutics 288, 260-269. (Pubitemid 29113499)
14. Kuzmin, A.V., Semenova, S., Gerrits, M.A., Zvartau, E.E., Van Ree, J.M., 1997. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. European Journal of Pharmacology 321, 265-271. (Pubitemid 27106827)
15. Liang, J., Ping, X.J., Li, Y.J., Ma, Y.Y.,Wu,L.Z., Han, J.S., Cui, C.L., 2010. Morphine-induced conditioned place preference in rats is inhibited by electroacupuncture at 2 Hz: role of enkephalin in the nucleus accumbens. Neuropharmacology 58, 233-240.
16. Ling, L.J., Wong, G.T., Yao, L., Xia, Z., Irwin, M.G., 2010. Remote pharmacological post-conditioning by intrathecal morphine: cardiac protection from spinal opioid receptor activation. Acta Anaesthesiologica Scandinavica 54, 1097-1104.
17. Narita, M., Kishimoto, Y., Ise, Y., Yajima, Y., Misawa, K., Suzuki, T., 2005. Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state. Neuropsychopharmacology 30, 111-118. (Pubitemid 40024405)
18. Omiya, Y., Goto, K., Suzuki, Y., Ishige, A., Komatsu, Y., 1999. Analgesia-producing mechanism of processed Aconiti tuber: role of dynorphin, an endogenous kappaopioid ligand, in the rodent spinal cord. Japanese Journal of Pharmacology 79, 295-301. (Pubitemid 29168139)
19. Pan, Z.Z., 1998. mu-Opposing actions of the kappa-opioid receptor. Trends in Pharmacological Sciences 19, 94-98.
20. Paxinos, G., Watson, C., 1997. The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
21. Shippenberg, T.S., Zapata, A., Chefer, V.I., 2007. Dynorphin and the pathophysiology of drug addiction. Pharmacology & Therapeutics 116, 306-321. (Pubitemid 47454747)
22. Shirasaki, S., Minamoto, N., Tsukada, S., 1999. The analgesic effect of 'Bushi' powder, and combination with epidural nerve block, for chronic back and leg pain in aged patients. Pain and Kampo Medicine 9, 23-26 (abstract in English, article in Japanese).
23. Shu, H., Arita, H., Hayashida, M., Chiba, S., Sekiyama, H., Hanaoka, K., 2006a. Inhibition of morphine tolerance by processed Aconiti tuber is mediated by kappa-opioid receptors. Journal of Ethnopharmacology 106, 263-271. (Pubitemid 43766191)
24. Shu, H., Arita, H., Hayashida, M., Sekiyama, H., Hanaoka, K., 2006b. Effects of processed Aconiti tuber and its ingredient alkaloids on the development of antinociceptive tolerance to morphine. Journal of Ethnopharmacology 103, 398-405. (Pubitemid 43143376)
25. Shu, H., Hayashida, M., Chiba, S., Sekiyama, H., Kitamura, T., Yamada, Y., Hanaoka, K., Arita, H., 2007. Inhibitory effect of processed Aconiti tuber on the development of antinociceptive tolerance to morphine: evaluation with a thermal assay. Journal of Ethnopharmacology 113, 560-563. (Pubitemid 47361560)
26. Shu, H., Hayashida, M., Huang, W., An, K., Chiba, S., Hanaoka, K., Arita, H., 2008. The comparison of effects of processed Aconiti tuber, U50488H and MK-801 on the antinociceptive tolerance to morphine. Journal of Ethnopharmacology 117, 158-165.
27. Specker, S., Wananukul, W., Hatsukami, D., Nolin, K., Hooke, L., Kreek, M.J., Pentel, P.R., 1998. Effects of dynorphin A(1-13) on opiate withdrawal in humans. Psychopharmacology (Berl) 137, 326-332.
28. Staley, J.K., Rothman, R.B., Rice, K.C., Partilla, J., Mash, D.C., 1997. Kappa2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims. Journal of Neuroscience 17, 8225-8233. (Pubitemid 27461047)
29. Suzuki, Y., Goto, K., Ishige, A., Komatsu, Y., Kamei, J., 1999. Antinociceptive effect of Gosha-jinki-gan, a Kampo medicine, in streptozotocin-induced diabetic mice. Japanese Journal of Pharmacology 79, 169-175. (Pubitemid 29140006)
30. Taki, M., Omiya, Y., Suzuki, Y., Ikeda, Y., Noguchi, M., Matuba, T., Kubo, M., Niitu, K., Komatsu, Y., Okada, M., 1998. Quality and pharmacological investigation of processed Aconiti Tuber (TJ-3022). Natural Medicines 52, 343-352 (abstract in English, article in Japanese).
31. Tsuji, M., Takeda, H., Matsumiya, T., Nagase, H., Narita, M., Suzuki, T., 2001. The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice. Life Sciences 68, 1717-1725. (Pubitemid 32245620)
32. Tzschentke, T.M., 1998. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Progress in Neurobiology 56, 613-672. (Pubitemid 29012461)
33. Unterwald, E.M., Rubenfeld, J.M., Kreek, M.J., 1994. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport 5, 1613-1616. (Pubitemid 24265254)
34. van Ree, J.M., Gerrits, M.A., Vanderschuren, L.J., 1999. Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacological Reviews 51, 341-396. (Pubitemid 29269983)
35. Walsh, S.L., Strain, E.C., Abreu, M.E., Bigelow, G.E., 2001. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology (Berl) 157, 151-162. (Pubitemid 32802126)
36. Wang, Y.H., Sun, J.F., Tao, Y.M., Chi, Z.Q., Liu, J.G., 2010. The role of kappa-opioid receptor activation in mediating antinociception and addiction. Acta Pharmacologica Sinica 31, 1065-1070.
37. Wee, S., Koob, G.F., 2010. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology (Berl) 210, 121-135.
38. Xu, H., Arita, H., Hayashida, M., Zhang, L., Sekiyama, H., Hanaoka, K., 2006. Pain-relieving effects of processed Aconiti tuber in CCI-neuropathic rats. Journal of Ethnopharmacology 103, 392-397. (Pubitemid 43143375)
39. Yu, J., Butelman, E.R., Woods, J.H., Chait, B.T., Kreek, M.J., 1997. Dynorphin A (1-8) analog, E-2078, crosses the blood-brain barrier in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics 282, 633-638. (Pubitemid 27340161)
40. Zhai, H., Wu, P., Xu, C., Liu, Y., Lu, L., 2008. Blockade of cue- and drug-induced reinstatement of morphine-induced conditioned place preference with intermittent sucrose intake. Pharmacology Biochemistry & Behavior 90, 404-408.